FDA seeks to reduce animal testing requirements for mAbs, other drugs
Regulatory NewsJeff Craven
Biologics/ biosimilars/ vaccinesBiotechnologyPharmaceuticalsPreclinicalPreclinical studyUnited StatesRegulatory NewsJeff CravenBiologics/ biosimilars/ vaccinesBiotechnologyPharmaceuticalsPreclinicalPreclinical studyUnited States